Design of a pharmacokinetic/pharmacodynamic model for administration of low dose peripheral norepinephrine during general anaesthesia

Documenti analoghi

• Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants
  di: Clifford G. Banda, et al.
  Pubblicazione: (2024)
• Population kinetic/pharmacodynamic modelling of the haemodynamic effects of cafedrine/theodrenaline (Akrinor) under general anaesthesia
  di: Christiane Dings, et al.
  Pubblicazione: (2024)
• Clinical pharmacokinetics and pharmacodynamics of empagliflozin in patients with heart failure
  di: Juliane Rascher, et al.
  Pubblicazione: (2024)
• Randomised, phase 1 evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of iptacopan in healthy volunteers
  di: Irina Baltcheva, et al.
  Pubblicazione: (2026)
• Clinical study of the pharmacokinetics and pharmacodynamics of Xininurad tablets in patients with renal impairment
  di: Xiaoni Wang, et al.
  Pubblicazione: (2025)